The Scientist

» hESCs, microbiology and disease/medicine

Most Recent

From sequencing bacteriophages to synthesizing bacterial genomes to defining a minimal genome

0 Comments

image: Cullen Buie Parses Pathogens With Passion

Cullen Buie Parses Pathogens With Passion

By | August 1, 2016

Associate Professor, Department of Mechanical Engineering, MIT. Age: 34

1 Comment

By ditching traditional agar-based media, two biochemists captured iconic images of Myxococcus in 1982.

0 Comments

image: Moving Toward Personalized Autism Treatment

Moving Toward Personalized Autism Treatment

By | August 1, 2016

Researchers aim to leverage new insights into the underlying causes of the disorder to better help patients. 

0 Comments

image: On Becoming Human

On Becoming Human

By | August 1, 2016

Some thoughts on going to the Galápagos

1 Comment

image: Riboswitch Screen

Riboswitch Screen

By | August 1, 2016

A newly developed method detects regulators of bacterial transcription called riboswitches.

0 Comments

image: Wanted: Transcriptional Regulators

Wanted: Transcriptional Regulators

By | August 1, 2016

Researchers have designed a screen to find unique molecules, called riboswitches, that determine whether transcription will proceed.

0 Comments

image: Humans Never Stopped Evolving

Humans Never Stopped Evolving

By | August 1, 2016

The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

7 Comments

image: The Genes Underlying Autism Are Coming Into Focus

The Genes Underlying Autism Are Coming Into Focus

By | August 1, 2016

As researchers sequence the DNA of thousands of kids with autism, dozens of genetic subgroups are emerging.

1 Comment

image: Contributors

Contributors

By | August 1, 2016

Meet some of the people featured in the August 2016 issue of The Scientist.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham